EU regulator 'convinced' AstraZeneca benefit outweighs risk

With coronavirus cases rising in many places, governments faced the grimmest of dilemmas Tuesday: push on with a vaccine that is known to save lives or suspend use of AstraZeneca over reports of dangerous blood clots in a few recipients, even as the European regulator said there was 'no indication' the shot was responsible.